Integrative systems biology, transcriptomic profiling, and experimental validation reveal enterolactone as a multi-target inhibitor of metastatic signalling in triple-negative breast cancer

Authors:

Abstract
No abstract available
Funding Information
  • Bharati Vidyapeeth
  • Department of Biotechnology, Ministry of Science and Technology, India

This publication has 88 references indexed in Scilit: